Publication | Closed Access

A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease

ObesityMetabolic SyndromeNutritionOverweight ChildrenHepatologyLiver PhysiologyPediatricsChild NutritionLiver DiseaseHepatic FatFatty Liver DiseasePublic HealthMedicineAtherosclerosisDocosahexaenoic Acid Supplementation